Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
SVB Leerink Maintains Outperform on Xeris Biopharma Holdings, Lowers Price Target to $5
SVB Leerink analyst Roanna Ruiz maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform and lowers the price target from $6 to $5.
Xeris Biopharma Announces Plans For A Phase II Dose-Finding Study For Its Investigational Subcutaneous Levothyroxine As Replacement Therapy For Hypothyroidism
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today
Xeris Biopharma Announces Research Collaboration And Option Agreement With Horizon Therapeutics plc For XeriJect Formulation Of Teprotumumab
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today
Xeris Biopharma Announces Results Of The Extended Evaluation Of Recorlev From The Phase 3 Sonics Study Published In The European Journal Of Endocrinology
First prospective long-term levoketoconazole study demonstrating a sustained effect on cortisol levels, as well as improvements in biomarkers of Cushing's syndrome (CS) comorbidity, clinical signs and symptoms
Xeris Biopharma Posts Encouraging Data From Reformulated Thyroid Hormone Deficiency Treatment In Healthy Participants
Xeris Biopharma Holdings Inc (NASDAQ:XERS) announced topline results from its Phase 1 study of subcutaneous (SC) levothyroxine (XP-8121) in healthy adult…
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
73 Biggest Movers From Yesterday
Gainers
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.